• Enabling

    Enabling

    Knowledge, Skills and Big Data

  • Innovation and Creation

    Innovation and Creation

    Open Mindset and Think Disruptive

  • Planning Forward

    Planning Forward

    Focus, Ensuring Performance and Success

  • Growth and Sustainability

    Growth and Sustainability

    Assuring Shareholder Values and Returns

  • Staff and Family

    Staff and Family

    High Impact Performance and Quality Life

  • Corporate Social Responsibilities

    Corporate Social Responsibilities

    Living Harmoniously with Nature and Communities

Dengue Statistics: 2019



In 2019, Malaysia recorded the highest number of dengue cases in four years with over 130,000, rising 61 per cent from 2018.
A total of 2,694 dengue cases were recorded in the last week of 2019, rising 2.4 per cent from the previous week. This brings the total number of dengue cases in Malaysia for 2019 to 130,101 as of December 28, beating the previous historic high of 120,836 cases reported in 2015.
According to the Ministry of Health’s (MOH) Crisis Preparedness Response Centre (CPRC), there were 80,615 cases for the same period in 2018. Last year’s cases, as of December 28, saw an increase of 61.4 per cent, or 49,486 cases, from the same period in 2018.
Meanwhile, six dengue-related deaths were reported from December 22 to December 28, bringing the total number of deaths to 182 for 2019. The figure was 147 during the same period last year. A total of 336 deaths were recorded in 2015.
Dengue-related deaths for all states and federal territories, excluding Perlis and Labuan, which recorded no deaths, averaged below 60.
Graphic from the Ministry of Health’s Crisis Preparedness Response Centre (CPRC).
Selangor, still remains at the top of the list of states with cumulative dengue cases for 2019 up to December 28, recording a staggering 72,543 cases, and 56 dengue-related deaths. This is an increase of 60 per cent in dengue cases for the same period in 2018. Selangor recorded 45,349 cases and 41 deaths up to the 52nd week of 2018.
Kuala Lumpur and Putrajaya remained in second place, recording 15,424 cases and 10 deaths from January to December 28, 2019, a 103.2 per cent increase in dengue cases from the same period in 2018, where the two federal territories recorded 7,591 cases and 11 deaths.
Johor, Kelantan, and Sabah remained in third, fourth, and fifth places, recording 10,873, 6,003, and 5,478 cases, respectively, during the same period.
The other states and the number of dengue cases recorded last year (as of December 28, 2019) are as follows: Penang (4,119), Perak (3,226), Pahang (2,873), Sarawak (2,648), Negri Sembilan (2,305), Melaka (2,156), Kedah (1,587), Terengganu (542), Perlis (288), and Labuan (36).
Tudan Flat in Miri, Sarawak, recorded the highest number of cases according to district localities, with 59 cases last year as of December 28, followed by Taman Serkam Jaya in Jasin, Melaka (55 cases), and Block H-M at Pangsapuri Baiduri Bandar Tasik Kesuma in Hulu Langat, Selangor (48 cases).
CPRC also said that 55 chikungunya cases were reported from December 22 to 28 last year, bringing the total number of recorded cases for 2019 up to December 28, to 990.
One positive case of zika was also reported during that same week, bringing the number of zika cases from January to December 28, 2019, to one. This came after the National Public Health Lab and Institute of Medical Research screened 2,792 blood samples and 51 urine samples of those suspected to have zika, as part of its zika surveillance.
/CodeBlue 03-01-2020


Disclaimer: Views or opinions expressed are solely those of the Author and should be used with discretion. The Author shall not be held liable for any acts or omissions arising from the use of the information. The user will be personally liable for any damages or other liability arising hereof.


Read more

Cervical Cancer



Cervical cancer is the third most common cancer among Malaysian women.
Head of Cancer and Health Screening Clinics of the National Cancer Society of Malaysia (NCSM), Dr Dalilah Kamaruddin, said that, previously, cervical cancer was named the second most common cancer in Malaysia, but this had changed over the years due to the increased awareness among women.

“I can positively say that the public awareness on cervical cancer is much better these days as people are more exposed and informed about this illness, thus making them come forward to have their health screenings done.
“However, despite the fact that more people are aware of cancer, there are still many people who refuse to get themselves checked as they are too shy to do so,” she said.
Dr Dalilah said that based on the International Agency for Research on Cancer (GLOBOCAN) statistics, in every four minutes a woman would die of cervical cancer in the Asia Pacific region, which includes Malaysia.
She said that this statistics crucially showed that cervical cancer could not be taken lightly by women, but instead should seen as an illness that needed early diagnosis and treatment.
“Women from all ages and walks of life must clearly understand that if this cancer is detected earlier, then the chance of recovery is much better,” she said.
She also added that in years to come, the number of women suffering from cervical cancer might drop as many women had become more health conscious, led a healthy lifestyle and were more open to talk about the deadly illness.
“I would also like to call on all the ladies out there to do their Pap Smears regularly, to have themselves vaccinated, to practice safe sex and to maintain their general health,” she added.

Disclaimer: Views or opinions expressed are solely those of the Author and should be used with discretion. The Author shall not be held liable for any acts or omissions arising from the use of the information. The user will be personally liable for any damages or other liability arising hereof.


Read more

Colorectal Cancer: National Cancer Registry 2007-11



Colorectal Cancer (CRC) is the most common of cancer types among men and the second most common among women in Malaysia at a prevalence of 13.2 per cent, as reported in the Malaysian National Cancer Registry Report (2007 – 2011).
Statistics showed that the incidence of the disease is highest among the Chinese, followed by Malays and Indians. The figures also revealed that the mortality rate for males was 1.42 times higher as compared to females.
The most common symptoms of the disease are altered bowel habit (41.7 per cent) followed by blood in stool (35.5 per cent), abdominal pain, (31.5 per cent), weight loss (31.0 per cent), anaemia (9.8 per cent) and intestinal obstruction (9.3 per cent).
These alarming figures were revealed by Health Director General Datuk Dr Noor Hisham Abdullah at the launch of the Clinical Practice Guidelines (CPG), which is the first of its kind handbook on the management of colorectal carcinoma at Hospital Selayang.
“Unfortunately, a majority of patients are at stage three and four (54.36 per cent), while only 8.4 per cent are diagnosed at stage one when they seek medical assistance".
He said some of the main causes in the rise of the disease was due to the unhealthy Malaysian lifestyle, in particular, the consumption of too much red meat and processed food, as well as the low intake of fibre.
“Genetics, consuming alcohol, smoking and lack of exercise are also contributing risk factors,” Dr Noor warned.
He pointed out that with the ever increasing number of new cases detected every year, the economic burden of CRC management is escalating especially if the patients are at the advanced stage.
“Hence, the introduction of screening programmes should be undertaken for early detection of the cancer which can ultimately reduce the economic burden of CRC, to the individual, family and country.
“Today, the estimated societal cost of CRC management in government hospitals in Malaysia using conventional chemotherapy ranges between RM13,622 and RM27,163 based on different stages, with an average of RM21,377 per patient. Early detection will not only save lives but also ease financial burden.
Among those present at the launch were colorectal specialist and chairman of the CPG steering committee Dr Nil Amri Mohamed Kamil and Hospital Selayang director Dr Sakinah Alwi.
/NST  27-06-2018

Disclaimer: Views or opinions expressed are solely those of the Author and should be used with discretion. The Author shall not be held liable for any acts or omissions arising from the use of the information. The user will be personally liable for any damages or other liability arising hereof.


Read more

Cancer on the Rise: National Cancer Registry 2012-16



Cancer cases in Malaysia have been increasing for the past 10 years, and it remains the second highest cause of death, based on the Malaysia National Cancer Registry Report (MNCRR) 2012-2016.
Health Director General Datuk Dr Noor Hisham Abdullah said cancer cases in the country had increased to 115,238 from 2012 to 2016, compared to 103,507 from 2007 to 2011.
“In 2018, cancer took 9.6 million lives worldwide, with 16,000 lives in Malaysia alone.”
He said 86 out of every 100,000 males and 102 out of every 100,000 females had cancer.
For the period 2012-2016, 10 types of cancer were detected among Malaysians. They were breast, colorectal, lung, lymphoma, nasopharynx, leukemia, prostate, liver, cervical and ovarian cancers.
It was discovered that men were mostly affected by lung and prostate cancer, while women are most affected by breast, colorectal and cervical cancer.
Meanwhile, the types of cancer usually detected among children aged 0 to 14 were leukemia and spinal cord cancer, while youngsters between the age of 15 and 24 were prone to lymphoma.
The rate of cervical cancer, however, is seeing a downward trend from eight to six cases for every 100,000 females in the country, and this is probably due to awareness campaigns involving early detection such as pap smear, according to the report.
“Nevertheless, there is a significant increase in breast and colorectal cancers.”
Dr Noor Hisham said analysis based on ethnicity found that the Chinese were more prone to cancer than the Malays and Indians.
For every 100,000 Chinese population, it was found that 106 men and 117 women had cancer.
However, if compared (this report) to the previous one, there is a downward trend in regard to cancer cases related to the Chinese and Indians, while it is increasing among the Malays.
“Late cases where there was only detection at the third and fourth stages is also increasing from 58.7 per cent from 2007 to 2011, to 63.7 per cent from 2012 to 2016,” he said.



/NST 03-01-2020

Disclaimer: Views or opinions expressed are solely those of the Author and should be used with discretion. The Author shall not be held liable for any acts or omissions arising from the use of the information. The user will be personally liable for any damages or other liability arising hereof.


Read more

IHH to acquire Prince Court Medical Centre by Q1,2020



IHH Healthcare Bhd is expected to complete the acquisition of Prince Court Medical Centre in the first quarter 2020 on near unanimous shareholder support.
The government-linked health care provider announced that an extraordinary general meeting today, more than 99.99 per cent of non-interested IHH shareholders and proxies voted in favour of the conditional share purchase agreement between IHH’s wholly-owned subsidiary, Pantai Holdings Sdn Bhd, and Pulau Memutik Ventures Sdn Bhd, a wholly-owned subsidiary of Khazanah Nasional Berhad, for the acquisition of the entire issued share capital of Prince Court Medical Centre, for RM1.02 billion cash.
“This moves the Group closer to strengthening its market position in Malaysia and allowing it to better serve patient needs in the country,” IHH said in a statement.
Once the transaction is completed, Prince Court Medical Centre will become IHH’s 16th hospital in Malaysia. IHH currently runs Pantai and Gleneagles Hospitals in Malaysia.
Strategically located in the “Golden Triangle” area of Kuala Lumpur, Malaysia, Prince Court Medical Centre is a 277-bed private hospital offering a wide range of services including, among others, burns management, cancer, gastrointestinal diseases, interventional cardiology, in vitro fertilisation, nephrology, occupational health, orthopaedic and rehabilitation medicine.
“Adding Prince Court Medical Centre will empower us to bring our best-in-class care and outcomes to even more patients in Malaysia and abroad. With a broader network and stronger cluster of specialised tertiary hospitals in the Klang Valley, supported by a deeper clinical talent pool, IHH can offer a wider array of services and take on more complex cases.
“This will make our facilities even more compelling for both local and foreign patients, and further reinforces Malaysia’s attractiveness as a medical travel destination,” said Joe Sim, CEO of Malaysia Operations Division at IHH.
Prince Court Medical Centre medical director Dr Kuljit Singh said: “As part of the IHH Group, Prince Court Medical Centre can leverage on its scale and track record to unlock greater synergies and enhance our suite of service offerings and delivery of value-based care.”
/CodeBlue 09-12-2019


Disclaimer: Views or opinions expressed are solely those of the Author and should be used with discretion. The Author shall not be held liable for any acts or omissions arising from the use of the information. The user will be personally liable for any damages or other liability arising hereof.


Read more

Fee Deregulation, Doctors still oppose Dispensing Separation



The Malaysian Medical Association (MMA) still does not support separating the prescribing and dispensing of medicines to doctors and pharmacists respectively, despite the deregulation of physicians’ professional charges.
The country’s largest association of doctors said various health stakeholders had agreed back in 2015 that dispensing separation could only come about in a national health financing system, or a single-payer system.
A single-payer system means health spending is primarily made by the government, rather than the current multi-payer system that sees health care payments made by the Health Ministry, the Education Ministry, other federal agencies, private insurance, corporations, and people’s own out-of-pocket payments, among others.
“It’s not only the consultation fees. We’re talking about government structure, how they’re going to do that. What about the restriction? What is the audit trail? Will there be a duplication? Will there be fraud in the prescription? Who’s going to audit that? So there are lots of factors involved.
“So MMA will only support only when we have a single-payer system, which was agreed upon by all parties,” MMA Honorary General Secretary Dr R. Arasu told radio station BFM today.
The physician also said there must first be an electronic medical record (EMR) system that integrates patients’ medical histories between public and private health facilities, pharmacies, and general practitioner (GP) clinics.
“We must make sure the building blocks are in place,” said Dr Arasu. “Until then, dispensing separation is not feasible.”
The Health Ministry recently tried to criminalise non-compliance of mandatory prescriptions upon request, but was forced to postpone subsequent readings of the Poisons (Amendment) Bill 2019 in Parliament to 2020 after physicians’ and dentists’ groups expressed outrage against proposals of incarceration and fines for rejecting patients’ prescription requests.
The Health Ministry made a surprise announcement recently that GPs, dentists and specialists in private clinics and hospitals would be free to set their own consultation fees, 13 years after the professional rates of private medical practitioners were first regulated by legislation.
Clinic GPs had long been demanding that their consultation charges of RM10 to RM35, a rate set since 1992, be increased to their hospital-based counterpart rates of RM30 to RM125.
Dr Arasu assured Malaysians today that the total encounter fee in private clinics would either remain the same or only see a “marginal increase”, despite the deregulation of family doctors’ professional charges.
“So what we foresee is that the medicine price will be reduced and the doctors will start charging appropriate consultation fees for the services they actually provide for the patients.
Dr Arasu also pointed out that the deregulation of family physicians’ consultation fees would encourage GPs to provide other health services, like preventive counseling.
/CodeBlue 12-12-2019
Disclaimer: Views or opinions expressed are solely those of the Author and should be used with discretion. The Author shall not be held liable for any acts or omissions arising from the use of the information. The user will be personally liable for any damages or other liability arising hereof.


Read more

Proposed Health Activities for 2020



Malaysia is expected to see a revamped Health Financing System (HFS) if the Cabinet approves the healthcare reform proposal by the Health Ministry.

Minister Datuk Seri Dr Dzulkefly Ahmad said he planned to bring the Sihat Bersama (Health Together) 2030 proposal to the Cabinet before the end of January 2020.

A sustainable (1) HFS (2) public sector transformation through corporatisation in order to become more empowered, agile and responsive and (3) private sector regulatory reform. These are the three pillars outlined in Sihat Bersama 2030 to transform the healthcare system.

“Unless you have the HFS in place, there’s no point in bringing reform in the government and private sector, ” Dzulkefly said. He said Sihat Bersama 2030, which is the health sector’s version of the Shared Prosperity Vision 2030, would enhance existing healthcare services and address issues such as the lack of funds, long waiting period, lack of medical staff, the burden of non-communicable diseases and an ageing population. It will be a comprehensive plan that will address the health systems and healthcare delivery issues in the country.

He said the purpose of the HFS was twofold – (1) to increase pooled and prepaid health financing in a sustainable, diversified manner that is equitable and affordable for households and employers and (2) to establish a well-governed health financing institution.

Once approved by the Cabinet, a task force would be set up to look into implementation studies and communication strategies.

In Sihat Bersama 2030, the electronic medical record (EMR) system that stores the records of patients in public health facilities nationwide would be introduced nationwide to cut down waiting times and enhance patient care and population health.

EMR would be made accessible to private medical centres too, and could be used for research and decision-making on public health issues, and that the ministry would request proposals from the private sector to undertake the project this year.

Meanwhile, the price control mechanism and pool procurement of medicine would be rolled out by mid-year, he said.

On other measures, Dzulkefly said housemanship training would be reduced from 24 months to 18 months, and there would be five postings for training instead of six.

He also hoped to address service delivery issues such as reducing the waiting time and congestion in public health facilities by setting up 20 clinics, having more clinics with extended hours and expanding the use of e-registration and e-wallet payments.

The government will also increase the number of virtual clinics from the current five, while selected follow-up cases could use the virtual clinics manned by the same doctors. 

On the concern over polio, the ministry has discussed with its Filipino counterpart about addressing the issue of stateless children in Sabah and the Philippines has agreed to fund polio vaccination of the children, with Unicef providing the cheaper vaccine that will be administered by NGOs.

The ministry has put in place a real-time surveillance dashboard to monitor disease outbreaks, hotspots, as well as facilities and doctors available.

When needed, district health officers would go to the ground to immunise the population at the hotspots.

As mentioned in the Budget 2020 announcement, pneumococcal vaccination will be rolled out this year, though no specific date has been set.

Meanwhile, the government will also expand the Skim Peduli Kesihatan (Peka B40) coverage to include individuals aged 40 and above from the low-income (B40) group.

Peka B40 provides health screenings and early intervention for non-communicable diseases such as cancer and mental health problems, and currently covers those aged 50 to 60.

A National Strategic Action Plan on Mental Health (2020-2025) will also be launched this year.


/theSTAR 02-01-2020



Disclaimer: Views or opinions expressed are solely those of the Author and should be used with discretion. The Author shall not be held liable for any acts or omissions arising from the use of the information. The user will be personally liable for any damages or other liability arising hereof.


Read more